Abstract
BackgroundRheumatoid arthritis (RA) patients benefit from treat-to-target strategies, aiming for remission or low disease activity1. Clinical disease activity measures like the Disease Activity Score (DAS28) have questionable reproducibility and lack...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have